Gamma activity model for treatment-resistant bipolar psychotic mania

Indian J Pharmacol. 2015 Mar-Apr;47(2):215-8. doi: 10.4103/0253-7613.153434.

Abstract

Objectives: The objective was to investigate the effect of clozapine on spontaneous gamma activity in treatment-resistant bipolar psychotic mania.

Methods: Patients with treatment-resistant (TR) bipolar psychotic mania on clozapine monotherapy and nontreatment-resistant bipolar psychotic mania patients receiving lithium were prospectively studied for 6 weeks on severity of psychopathology and 30-49 Hz gamma spectral power.

Results: Spectral power significantly increased in the lithium group and decreased in the clozapine group; no within group significant difference found.

Conclusions: We propose a model highlighting the role of gamma spectral power and modulations of GABAergic neurotransmission in TR bipolar psychotic mania.

Keywords: Bipolar psychotic mania; gamma activity; spectral power; treatment resistance.

MeSH terms

  • Adolescent
  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / therapeutic use*
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / physiopathology
  • Bipolar Disorder / psychology
  • Drug Resistance*
  • Functional Laterality
  • Gamma Rhythm / drug effects*
  • Humans
  • Lithium / administration & dosage
  • Lithium / therapeutic use*
  • Male
  • Middle Aged
  • Models, Neurological
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Young Adult

Substances

  • Antipsychotic Agents
  • Lithium